Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (461-470 of 494) with videos related to

Pageof 50
Sort By:
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
The New England Journal of Medicine|September 29, 2025
Hypertonic Saline or Carbocisteine in BronchiectasisJudy M Bradley, Brenda O'Neill, Daniel F McAuley, et al.
The Lancet Regional Health. Europe|June 1, 2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controlsBang Zheng, Giulia Vivaldi, Luke Daines, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
ERJ Open Research|July 16, 2024
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVIDOmer Elneima, John R Hurst, Carlos Echevarria, et al.
The Lancet. Psychiatry|August 3, 2024
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UKMaxime Taquet, Zuzanna Skorniewska, Thomas De Deyn, et al.
Clinical Endocrinology|January 17, 2024
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19Kerri Devine, Clark D Russell, Giovanny R Blanco, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
The European Respiratory Journal|February 20, 2025
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitationEnya Daynes, Rachael A Evans, Neil J Greening, et al.
Critical Care Medicine|March 7, 2020
Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care JournalsDaniel E Leisman, Michael O Harhay, David J Lederer, et al.
Pageof 50

Showing results (461-470 of 494) with videos related to

Sort By:
Pageof 50
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
The New England Journal of Medicine|September 29, 2025
Hypertonic Saline or Carbocisteine in BronchiectasisJudy M Bradley, Brenda O'Neill, Daniel F McAuley, et al.
The Lancet Regional Health. Europe|June 1, 2023
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controlsBang Zheng, Giulia Vivaldi, Luke Daines, et al.
The Lancet. Respiratory Medicine|September 8, 2022
Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trialHolly R Keir, Merete B Long, Hani Abo-Leyah, et al.
ERJ Open Research|July 16, 2024
Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study - PHOSP-COVIDOmer Elneima, John R Hurst, Carlos Echevarria, et al.
The Lancet. Psychiatry|August 3, 2024
Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UKMaxime Taquet, Zuzanna Skorniewska, Thomas De Deyn, et al.
Clinical Endocrinology|January 17, 2024
Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19Kerri Devine, Clark D Russell, Giovanny R Blanco, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
The European Respiratory Journal|February 20, 2025
Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-based rehabilitationEnya Daynes, Rachael A Evans, Neil J Greening, et al.
Critical Care Medicine|March 7, 2020
Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care JournalsDaniel E Leisman, Michael O Harhay, David J Lederer, et al.
Pageof 50